Rbm10 can also increase the stability of p53 by inhibiting MDM2 mediated ubiquitination and degradation of p53 and prolong the half-life of p53 to induce apoptosis to inhibit cancer cell proliferation and induce apoptosis. Here, TP53 is linked to cancer.